Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours ยท Estimated delivery Aug 20 - Aug 25
After one-step purification using protein A affinity chromatography, this expressed Exendin-4-Fc was used in subsequent experiments
: Tablets Active Pharmaceutical Ingredient (API) : Type 2 Diabetes Treatment Pharmaceutical Manufacturing Research & Development : North America Europe Asia-Pacific South America Middle East & Africa : Ranbaxy Dr
Jabbour, J
Gastric Emptying Modulation GLP2 transiently delays gastric emptying, similar to selective GLP-1 receptor agonists: Slowed rate of nutrient absorption from the gastrointestinal tract Reduced postprandial glucose excursions Effect is most pronounced after initial doses and diminishes with continued treatment Contributes to improved glycemic control through multiple complementary mechanisms Central Nervous System Effects Appetite Regulation Both GIP and GLP-1 receptors are expressed in brain regions controlling appetite and food intake: Reduced food intake and appetite through central nervous system receptor activation Promotion of satiety signals leading to decreased caloric consumption Potential modulation of reward-related feeding behaviors Weight loss effects that appear mediated through both homeostatic and hedonic feeding pathways Clinical trials have demonstrated substantial weight reduction, with participants experiencing decreased appetite as a commonly reported effect of GLP2 treatment
US$ 29.82
US$ 26.43
US$ 24.10
US$ 24.75
